SCHEMBL6825813

SCHEMBL6825813

CC#CC(CC(C)C)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1057906 0.81 — —
SCHEMBL1057742 0.81 — —
SCHEMBL6137576 0.79 — —
SCHEMBL1058031 0.79 — —
SCHEMBL16218833 0.71 — —
SCHEMBL14952932 0.70 — —
SCHEMBL16209240 0.70 — —
SCHEMBL18649592 0.70 — —
SCHEMBL18029421 0.68 MEN1 (0.35) —
SCHEMBL8649774 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1439837-A1 PYRAZOLIDINONE COMPOUNDS AS LIGANDS OF THE PROSTAGLANDIN EP2 AND/OR EP4 RECEPTORS Applied Research Systems ARS Holding N.V. (AN) 2004-07-28 — — EP disclosed
WO-2003035064-A1 PYRAZOLIDINONE COMPOUNDS AS LIGANDS OF THE PROSTAGLANDIN EP2 AND/OR EP4 RECEPTORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2003-05-01 — — WO disclosed
Send feedback